Todd DeVries

Once‐weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Edward Keystone, Michael Schiff, Joel M. Kremer et al. · Arthritis & Rheumatism · 2004 · 286 citations

Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma

John A. Thompson, Brendan D. Curti, Bruce G. Redman et al. · Journal of Clinical Oncology · 2008 · 184 citations

Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome

Debraj GuhaThakurta, Nadeem A. Sheikh, Li-Qun Fan et al. · Clinical Cancer Research · 2015 · 130 citations · Full text

JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

Sham Mailankody, Myo Htut, Kelvin P. Lee et al. · Blood · 2018 · 124 citations

Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).

Sham Mailankody, Andrzej Jakubowiak, Myo Htut et al. · Journal of Clinical Oncology · 2020 · 121 citations

Clinical Immunology, Cell Therapy, Immunodeficiencies +26